The whole underlying theme here is this stigma and bias of not recognizing obesity as a disease like we do cancer and diabetes and everything else, says Florencia Halperin, an endocrinologist and chief medical officer at Form Health, an online medical weight loss clinic, For cancer, you would never have an employer who says, We're not covering this. Amanda Bonello, founder and CEO of the GLP-1 Collective, a nonprofit organization aiming to help patients access these medications, is not surprised at the lengths patients are going to
Hims & Hers' weight loss business continues to be a major focus for the company, and that segment is on pace to bring in $725 million in revenue in 2025, Yemi Okupe, Hims & Hers' chief financial officer, said during the Q3 call with investors in early November
The risk was more than three times as high among patients who had been taking a GLP-1 drug the longest, the study found
While Semaglutide has revolutionized medical weight loss with its remarkable efficacy, its appetite-suppressing effects can and will vary significantly from person to person
Do need to change my workout routine while Im taking oral semaglutide
Neither STEP 1 nor SUSTAIN 8 trials analysed the amount of non-fat lean tissue lost from the participants adipose tissue
